1. Home
  2. IZM vs ENSC Comparison

IZM vs ENSC Comparison

Compare IZM & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICZOOM Group Inc.

IZM

ICZOOM Group Inc.

HOLD

Current Price

$0.26

Market Cap

4.5M

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.43

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IZM
ENSC
Founded
2011
2003
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
3.9M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
IZM
ENSC
Price
$0.26
$0.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
211.9K
21.4M
Earning Date
10-24-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.24
EPS
N/A
N/A
Revenue
N/A
$5,066,650.00
Revenue This Year
N/A
$55.01
Revenue Next Year
N/A
$1,033.97
P/E Ratio
$10.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.23
52 Week High
$2.73
$2.75

Technical Indicators

Market Signals
Indicator
IZM
ENSC
Relative Strength Index (RSI) 43.39 65.10
Support Level $0.24 $0.27
Resistance Level $0.30 $0.65
Average True Range (ATR) 0.03 0.08
MACD 0.00 0.02
Stochastic Oscillator 38.27 27.08

Price Performance

Historical Comparison
IZM
ENSC

About IZM ICZOOM Group Inc.

ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: